Today’s guest post comes from Kay Morgan, Vice President of Drug Information Excellence at Elsevier.
Kay discusses her thoughts on the latest developments on rebate reform and drug price transparency reform. Learn more by downloading Elsevier’s white paper: Prescription Drug Transparency Reform: While You Wait.
Read on for Kay’s insights.
Read more »
Source: Post feed
